logo
#

Latest news with #NJEDA

NJ Rallies Investment Power, Leveraging Capital from Garden State Venture Partners to Drive MedTech and Maternal Health Innovation
NJ Rallies Investment Power, Leveraging Capital from Garden State Venture Partners to Drive MedTech and Maternal Health Innovation

Yahoo

time3 days ago

  • Business
  • Yahoo

NJ Rallies Investment Power, Leveraging Capital from Garden State Venture Partners to Drive MedTech and Maternal Health Innovation

GLASSBORO, N.J., July 25, 2025--(BUSINESS WIRE)--Two transformative healthcare announcements this week mark a new era for New Jersey's innovation economy—with Garden State Venture Partners (GSVP) emerging as a key catalyst behind both. 1. MedTech Strategic Innovation Centers Backed by GSVP & NJEDA On July 21, NJEDA and Rowan University unveiled a major initiative to launch a Strategic Innovation Center, with locations in Camden and Mullica Hill, supporting early-stage medical technology companies with critical lab space, mentorship, and commercialization resources. GSVP, a New Jersey-based venture firm committed to fueling statewide innovation, is helping to make this possible through venture capital funding for early-stage medtech companies. Read release 2. A First-of-Its-Kind Maternal and Infant Health Innovation Center in Trenton Just one day later, Governor Murphy and First Lady Tammy Murphy broke ground on a Trenton-based center dedicated to maternal and infant health equity. The MedTech Strategic Innovation Center will also have a presence at the Maternal and Infant Health Innovation Center, which will focus on medical technologies that address racial disparities in care. Once again, GSVP will play a central role in helping bridge the gap between public health needs and private-sector innovation by accelerating promising, equity-driven health tech ventures. Read release Together, these initiatives represent over $100 million in coordinated investment, a model of public-private partnership, and a strategic bet on New Jersey as the next national hub for health tech and equity-focused innovation. GSVP's leadership and capital are essential to making that vision real. About Garden State Venture Partners Garden State Venture Partners (GSVP) is a next-gen venture capital firm built to attract and retain companies and talent within the state of New Jersey. GSVP is uniquely positioned to deepen existing partnerships and forge new ones across the state—catalyzing innovation and driving sustained economic success by connecting and investing in the state's innovation ecosystem. Learn more about GSVP at and access full leadership team bios here. View source version on Contacts Media Contact:Colleen Kendrick, CEONonprofit Partnersckendrick@ 1-800-298-9812 ext. 1

NJ Rallies Investment Power, Leveraging Capital from Garden State Venture Partners to Drive MedTech and Maternal Health Innovation
NJ Rallies Investment Power, Leveraging Capital from Garden State Venture Partners to Drive MedTech and Maternal Health Innovation

Business Wire

time3 days ago

  • Business
  • Business Wire

NJ Rallies Investment Power, Leveraging Capital from Garden State Venture Partners to Drive MedTech and Maternal Health Innovation

GLASSBORO, N.J.--(BUSINESS WIRE)--Two transformative healthcare announcements this week mark a new era for New Jersey's innovation economy—with Garden State Venture Partners (GSVP) emerging as a key catalyst behind both. These initiatives represent over $100 million in coordinated investment, a model of public-private partnership, and a strategic bet on New Jersey as the next national hub for health tech and equity-focused innovation. Share 1. MedTech Strategic Innovation Centers Backed by GSVP & NJEDA On July 21, NJEDA and Rowan University unveiled a major initiative to launch a Strategic Innovation Center, with locations in Camden and Mullica Hill, supporting early-stage medical technology companies with critical lab space, mentorship, and commercialization resources. GSVP, a New Jersey-based venture firm committed to fueling statewide innovation, is helping to make this possible through venture capital funding for early-stage medtech companies. Read release 2. A First-of-Its-Kind Maternal and Infant Health Innovation Center in Trenton Just one day later, Governor Murphy and First Lady Tammy Murphy broke ground on a Trenton-based center dedicated to maternal and infant health equity. The MedTech Strategic Innovation Center will also have a presence at the Maternal and Infant Health Innovation Center, which will focus on medical technologies that address racial disparities in care. Once again, GSVP will play a central role in helping bridge the gap between public health needs and private-sector innovation by accelerating promising, equity-driven health tech ventures. Read release Together, these initiatives represent over $100 million in coordinated investment, a model of public-private partnership, and a strategic bet on New Jersey as the next national hub for health tech and equity-focused innovation. GSVP's leadership and capital are essential to making that vision real. About Garden State Venture Partners Garden State Venture Partners (GSVP) is a next-gen venture capital firm built to attract and retain companies and talent within the state of New Jersey. GSVP is uniquely positioned to deepen existing partnerships and forge new ones across the state—catalyzing innovation and driving sustained economic success by connecting and investing in the state's innovation ecosystem. Learn more about GSVP at and access full leadership team bios here.

The Greenway: Construction begins on NJ's newest rail-to-trail park
The Greenway: Construction begins on NJ's newest rail-to-trail park

Yahoo

time19-07-2025

  • Business
  • Yahoo

The Greenway: Construction begins on NJ's newest rail-to-trail park

Local, county and state officials gathered in Newark on July 15 to kick off work on the first phase of The Greenway — the state's newest park. The Greenway is a 9-mile, 100-foot-wide former rail line that stretches through Essex and Hudson counties. The rail line will be fully restored, offering residents alternative ways of transportation, various green spaces, outdoor gathering spots and other amenities. The New Jersey Department of Environmental Protection is leading the project while the New Jersey Economic Development Authority is overseeing construction. NJ Transit is also collaborating in the project and will potentially expand the Secaucus-Meadowlands Transitway into the park. Once complete, The Greenway will connect eight municipalities: Jersey City, Secaucus, Kearny, Newark, Belleville, Bloomfield, Glen Ridge and Montclair. Story continues below embed. The Newark portion of The Greenway will span a mile from Branch Brook Park to Broadway Avenue, with the path being ADA compliant and lined with native plants. The linear path will feature downward-facing lighting and designated lanes for cyclists and walkers, encouraging safe speeds and practices for all. There will be three major gathering spaces along the path: The Newark Central Activity Center will be between Summer and Broadway Avenue. It will have a stage and lawn, playground and water play area, multi-sport courts, outdoor exercise stations, picnic tables, and restrooms. The Tiffany Manor Community Space will be located between Manchester Place and Greenwood Lake Street, across from the Tiffany Manor. This area will have central seating and space for short-term amenities, including food trucks. Rain gardens and native plants will surround the area. The Branch Brook Park Overlook will be west of the Tiffany Manor. An observation deck will be built that overlooks the 360-acre Branch Brook Park. Nearby, visitors can walk to Belleville Park and the Hendricks Field Golf Course. Story continues below video. This segment of The Greenway represents the largest single investment in state history for the development of a new state park at $69.2 million. This phase is to be completed by the end of 2026. Want to discover more walkways across Jersey? Check these out: Hudson River Waterfront Walkway (18.5 miles) Spanning from Fort Lee to Bayonne, this scenic waterfront features parks, seating and skyline views. The path connects several riverfront towns and offers uninterrupted stretches for pedestrians and cyclists along the Hudson River. Pompton Valley Rail Trail (5.1 miles) Opened in June 2025, this recreational path was built on a former railway. The trail goes from Pequannock Township to Wayne and connects neighborhoods and the Mountain View Train Station. West Essex Trail (2.8 miles) This Essex County trail spans the former 10468026002. Featuring remnants of the original railroad, the trail is a historic and quaint place for walking, hiking and biking. This article originally appeared on The Greenway: Construction begins on NJ's newest rail-to-trail park Solve the daily Crossword

ProBio Opens Flagship U.S. Plasmid & Viral Vector Manufacturing Facility in Hopewell, New Jersey to Advance Cell and Gene Therapy
ProBio Opens Flagship U.S. Plasmid & Viral Vector Manufacturing Facility in Hopewell, New Jersey to Advance Cell and Gene Therapy

Malaysian Reserve

time27-06-2025

  • Business
  • Malaysian Reserve

ProBio Opens Flagship U.S. Plasmid & Viral Vector Manufacturing Facility in Hopewell, New Jersey to Advance Cell and Gene Therapy

HOPEWELL, N.J., June 27, 2025 /PRNewswire/ — ProBio, a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy, today announced the opening of its flagship Cell and Gene Therapy Center of Excellence at the Princeton West Innovation Campus in Hopewell, New Jersey. The 128,000 sq ft GMP facility is purpose-built for manufacturing high-quality plasmid DNA and viral vectors, including adeno-associated virus (AAV) and lentiviral vector (LVV) platforms, reflecting ProBio's dedication to accelerating the delivery of transformative medicines. The celebration included an open house event featuring a guided site tour, ribbon-cutting ceremony, and a keynote address by Donavon Decker, the first person in the world to receive gene therapy for any form of muscular dystrophy in 1999. Decker shared his experience from that landmark trial at Ohio State University—led by Dr. Jerry Mendell—and spoke movingly about how state-of-the-art facilities like ProBio's Hopewell site help translate scientific advances into real patient outcomes. The ribbon-cutting ceremony featured remarks from prominent leaders: Debbie Hart, CEO of BioNJ; Courtney Peters–Manning, Mayor of Hopewell Township; John Coelho of the New Jersey Economic Development Authority (NJEDA); Michael Vreeland, Site Head of ProBio Hopewell; Allen Guo, CEO of ProBio; and Frank Zhang, Founder of GenScript and Chairman of Legend Biotech. Mayor Courtney Peters-Manning welcomed the company warmly, stating: 'Hopewell Township is a wonderful place to live and work, and we are thrilled to welcome ProBio to our community, where they will make cutting-edge, life-changing therapies, in addition to creating high-skilled jobs.' John Coelho of NJEDA emphasized the strategic significance of the opening: 'The opening of ProBio, a state-of-the-art fully integrated end-to-end Contract Development and Manufacturing Organization, will be a significant enhancement to the cell and gene biologics development and biomanufacturing ecosystem, anchoring New Jersey as a leader in the field. The potential to support production for global clinical trial registrations and close proximity to leading precision medical centers will enable faster access of breakthrough medicines to patients.' Built to meet the most rigorous GMP standards, the Hopewell site is equipped to support clinical-stage development, process-development and scale-up for cell and gene therapy programs. This capability solidifies New Jersey's position as a leader in biopharmaceutical manufacturing. During the open house, guests toured advanced GMP suites and production lines, and engaged with ProBio's scientific and operations teams as well as industry, academic, and government partners. 'This is not just a new facility. It is a beacon of hope for patients waiting for cures,' said Allen Guo, CEO of ProBio. 'Opening the Hopewell center is a milestone in ProBio's global expansion and underscores our mission to support biopharma innovators with high-quality, responsive manufacturing solutions.' Bringing over 110 high-skilled jobs to New Jersey, ProBio's Hopewell facility continues to expand its capabilities. GMP AAV manufacturing is set to launch by Q3 2025, with GMP LVV services to follow in Q1 2026—enabling support for a broader range of therapeutic candidates from early proof-of-concept through clinical readiness, all within one integrated site. Located in the heart of New Jersey's rapidly expanding innovation corridor, ProBio's Hopewell facility serves as the company's North American hub, designed to support and complement its broader operations across North America and Europe. This strategic investment aligns with efforts to strengthen transatlantic biomanufacturing capacity and resilience—positioning the site to meet growing demand for advanced therapeutic production across both continents. For more information about ProBio and its full suite of development and manufacturing services, please visit ABOUT PROBIO ProBio is a global leader in advancing the development and manufacturing of next generation biologics and advanced therapies for the biotech and pharmaceutical industries. As a fully integrated end-to-end Contract Development and Manufacturing Organization (CDMO), ProBio partners with its clients to optimize drug development, accelerate time-to-market, and provide comprehensive life-cycle support. Through a collaborative, risk-sharing approach, ProBio offers flexible licensing and co-development options for new therapeutics, enabling partners to effectively navigate the complexities of human disease with adaptable, cutting-edge therapeutic approaches. To learn more about ProBio services, please visit CUSTOMIZED CDMO SOLUTIONS. DEVELOPED FASTER. DELIVERED BETTER. Media Contact:Alvin Jogasuria Head of Marketing, Americas and Europe[email protected]

GK Digital Ventures to Launch 'The Global Game: The Future of Soccer, Tech & Media Summit' Adjacent to FIFA Club World Cup™ Final
GK Digital Ventures to Launch 'The Global Game: The Future of Soccer, Tech & Media Summit' Adjacent to FIFA Club World Cup™ Final

Business Wire

time12-06-2025

  • Business
  • Business Wire

GK Digital Ventures to Launch 'The Global Game: The Future of Soccer, Tech & Media Summit' Adjacent to FIFA Club World Cup™ Final

NEWARK, N.J.--(BUSINESS WIRE)--GK Digital Ventures, in collaboration with Harris Blitzer Sports & Entertainment (HBSE), today announced 'The Global Game: The Future of Soccer, Tech & Media Summit,' set to take place on July 10, 2025, at Prudential Center in Newark, NJ and will be supported by the New Jersey Economic Development Authority (NJEDA). The landmark event will coincide with the FIFA Club World Cup™, spotlighting New Jersey's growing role as a hub for innovation in global sports, media, and technology. It's about more than soccer—it's about how technology is reshaping everything from how we play to how we connect with fans around the world. Share With the overall theme 'Innovation at the Intersection of Soccer, Media, and Technology,' the Summit will convene top soccer executives, investors, team owners, media executives, tech leaders, and athletes for a day of future-focused discussions and unparalleled networking. Key topics include AI-driven performance, fan engagement, streaming innovation, and the expanding global footprint of soccer. Registration for 'The Global Game: The Future of Soccer, Tech & Media Summit' will be available on beginning Friday, June 13 at 12:00pm ET. For more information on event partnership opportunities please visit 'This summit reflects the next wave of innovation in global sports,' said Greg Kahn, CEO of GK Digital Ventures and Co-Founder of the event. 'It's about more than soccer—it's about how technology is reshaping everything from how we play to how we connect with fans around the world. I'm proud to partner with HBSE and the NJEDA to make New Jersey the launchpad for these conversations and collaborations.' 'As New Jersey steps onto the global stage—hosting the 2025 FIFA Club World Cup and 2026 World Cup Finals—we are excited to welcome The Global Game: The Future of Soccer, Tech & Media Summit to the Garden State,' said Governor Phil Murphy. 'As one of the premier locations for world-class sporting events and technology innovation, we are proud to welcome the world's best minds to our state to explore the future of the industry. New Jersey is where cutting-edge technology, creative storytelling, and passion for sport come together, building the next generation of content and experiences.' 'Under Governor Murphy's leadership, New Jersey has become a premier destination for large-scale sporting events – from March Madness to the World Cup,' said NJEDA Chief Executive Officer Tim Sullivan. 'The NJEDA is proud to sponsor this inaugural summit, which is an opportunity to connect New Jersey's global sports ecosystem with its thriving innovation economy – opening new doors for investment and job creation.' 'The convergence of sports, media, and technology has never been more powerful,' said Tad Brown, Chief Executive Officer, Harris Blitzer Sports & Entertainment. 'Our entire organization is very thankful to work in collaboration with Governor Murphy, the NJEDA, and Greg Kahn on this monumental summit. We are confident that the discussions taking place here in Newark on July 10 th will play an important role in shaping the future of the sport and its business.' 'As momentum builds toward the FIFA World Cup in 2026, events like this reflect the kind of forward-thinking energy that defines our region,' said Alex Lasry, CEO of the NYNJ Host Committee. 'New Jersey isn't just hosting eight matches, including the world's biggest game—we're helping shape the global conversation around the future of soccer.' Moderators and panelists confirmed to date include senior leaders from HBSE, Disney, U.S. Soccer, Paramount/CBS Sports, Fanatics, TEG Sport North America, and the FIFA World Cup 2026™ NYNJ Host Committee. Additional speakers and participants from across the global soccer, media, and tech industries will be announced soon — including, media executives, investors, and technology leaders, and top athletes who are shaping the future of the game. About GK Digital Ventures GK Digital Ventures is an investment and advisory firm focused on emerging media and technology, known for launching category-defining summits and building high-impact industry coalitions. About NJEDA The New Jersey Economic Development Authority is committed to driving inclusive, innovation-led economic growth across the Garden State. About Prudential Center Prudential Center is the world-class sports and entertainment venue located in downtown Newark, New Jersey. Opened in October 2007, the state-of-the-art arena is the home of the National Hockey League's (NHL) three-time Stanley Cup Champion New Jersey Devils, Seton Hall University's NCAA Division I Men's Basketball program, Professional Women's Hockey League's (PWHL) New York Sirens and more than 210 concerts, family shows and special events each year. Ranked in the Top 10 worldwide by Pollstar, Billboard and various other industry publications, Prudential Center is recognized as one of the premier venues in the United States, and hosts over 2 million guests annually. For more information about Prudential Center, visit and follow the arena on Facebook, X, Instagram, and TikTok @PruCenter. Prudential Center is a HBSE property.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store